NEW YORK, NY—A novel, robotically-made polymer surgical valve has an “acceptable safety” profile and stable hemodynamics through 1 year of follow-up in younger patients with symptomatic mitral valve ...

SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have surpassed 200 patient life years in human ...

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...

The one-year clinical trial results for a polymer-based heart valve are described as “compelling” by its manufacturer, Salt Lake City–based Foldax Inc. The company said the results showed a good ...

SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

A new type of synthetic heart valve could soon be available to help treat children living with chronic rheumatic heart disease. Researchers at Harvard University’s Wyss Institute and John A. Paulson ...

Peijia Medical Technology (Suzhou) has teamed up with dsm-firmenich Biomedical business to advance the research and development (R&D) of polymer heart valve materials. The parties have signed a ...